B A C Dijkmans
Overview
Explore the profile of B A C Dijkmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
5292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bossini-Castillo L, de Kovel C, Kallberg H, van t Slot R, Italiaander A, Coenen M, et al.
Ann Rheum Dis
. 2014 Feb;
74(3):e15.
PMID: 24532677
Introduction: Rheumatoid arthritis (RA) patients can be classified based on presence or absence of anticitrullinated peptide antibodies (ACPA) in their serum. This heterogeneity among patients may reflect important biological differences...
2.
Raterman H, Voskuyl A, Simsek S, Schreurs M, van Hoogstraten I, Peters M, et al.
Eur J Endocrinol
. 2013 Sep;
169(6):751-7.
PMID: 24005313
Objective: Autoimmune diseases such as rheumatoid arthritis (RA) and hypothyroidism tend to cluster, and this coexistence amplifies the elevated cardiovascular risk in RA. Whether thyroid peroxidase antibodies (TPOabs) are associated...
3.
van der Heijden J, Assaraf Y, Gerards A, Oerlemans R, Lems W, Scheper R, et al.
Scand J Rheumatol
. 2013 Aug;
43(1):9-16.
PMID: 23987246
Objectives: Although methotrexate (MTX) is the anchor drug in the treatment of rheumatoid arthritis (RA), patients experience clinical resistance to MTX upon prolonged treatment. We explored whether new-generation antifolates elicit...
4.
Dirven L, Klarenbeek N, van den Broek M, van Groenendael J, de Sonnaville P, Kerstens P, et al.
Clin Rheumatol
. 2012 Dec;
32(5):585-90.
PMID: 23224330
Objective: To determine incidence of increased levels of alanine transferase (ALT) >2× upper limit of normal (ULN) in patients receiving methotrexate (MTX), treated according to a dynamic strategy, and to...
5.
Jacobs J, Korswagen L, Schilder A, van Tuyl L, Dijkmans B, Lems W, et al.
Osteoporos Int
. 2012 Oct;
24(6):1827-33.
PMID: 23052940
Unlabelled: Long-term bone mineral density (BMD) changes and the associated factors in systemic lupus erythematosus (SLE) patients were assessed. Despite the remarkably low overall bone loss, significant spine bone loss...
6.
van Denderen J, Blom G, van der Horst-Bruinsma I, Dijkmans B, Nurmohamed M
Clin Rheumatol
. 2012 Sep;
31(12):1677-82.
PMID: 22941219
TNF-alpha blocking agents are very effective in patients with ankylosing spondylitis (AS), but several cases of liver problems have been published. We systematically studied the frequency of this potential side...
7.
Turkstra F, van Vugt R, Dijkmans B, Yazici Y, Yazici H
Clin Exp Rheumatol
. 2012 Jul;
30(3 Suppl 72):S10-3.
PMID: 22776270
Objectives: To determine the preferred treatment for patients with Behçet's syndrome. Methods: A questionnaire was given to all participants of the 2010 meeting of the International Society for Behçet's Disease....
8.
van der Weijden M, Claushuis T, Nazari T, Lems W, Dijkmans B, van der Horst-Bruinsma I
Clin Rheumatol
. 2012 Jun;
31(11):1529-35.
PMID: 22706444
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease. Decreased bone mineral density (BMD) is a common complication of AS, with a prevalence range of 19 to 62 %. Many...
9.
van den Broek M, Dirven L, Klarenbeek N, Molenaar T, Han K, Kerstens P, et al.
Ann Rheum Dis
. 2011 Nov;
71(2):245-8.
PMID: 22110122
Objective: Anticitrullinated protein antibodies (ACPAs) are suggested to identify different subsets of patients with rheumatoid arthritis (RA). The authors compared the clinical and radiological responses to Disease Activity Score (DAS)-steered...
10.
Dirven L, Visser K, Klarenbeek N, Ewals J, Han K, Peeters A, et al.
Scand J Rheumatol
. 2011 Nov;
41(1):15-9.
PMID: 22103436
Objective: Personalized treatment depends on the treatment goals. Current prediction models to guide initial treatment choices focus on radiological damage progression. However, for some patients this outcome is less relevant,...